Abstract
To the Editor: The modified Rankin Scale (mRS) is the most prevalent stroke outcome assessment in clinical trials, yet literature describing the properties of the scale remains limited,1 so we were pleased to see 2 papers describing clinometric assessment of mRS in the May issue of the Journal . Saver and colleagues describe a Rankin Focused Assessment Tool (RFAT),2 whereas Bruno’s group describes a simplified mRS questionnaire.3 The proposed use of structured assessment is in saving interviewers’ time and decreasing interobserver variability; both of these points are worthy of further discussion. The issue of time spent conducting mRS assessment is interesting. Based on collected data from 100 video-recorded, paired mRS interviews, we performed multivariate analysis to …
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call